Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 9045669)

1.

Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB.

Loo DT, Chalupny NJ, Bajorath J, Shuford WW, Mittler RS, Aruffo A.

J Biol Chem. 1997 Mar 7;272(10):6448-56.

2.

Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.

Rabu C, Quéméner A, Jacques Y, Echasserieau K, Vusio P, Lang F.

J Biol Chem. 2005 Dec 16;280(50):41472-81. Epub 2005 Oct 4.

3.
4.

Characterization of human homologue of 4-1BB and its ligand.

Zhou Z, Kim S, Hurtado J, Lee ZH, Kim KK, Pollok KE, Kwon BS.

Immunol Lett. 1995 Feb;45(1-2):67-73.

PMID:
7622190
5.

Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.

Futagawa T, Akiba H, Kodama T, Takeda K, Hosoda Y, Yagita H, Okumura K.

Int Immunol. 2002 Mar;14(3):275-86.

6.

A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity.

Yoshida H, Katayose Y, Unno M, Suzuki M, Kodama H, Takemura S, Asano R, Hayashi H, Yamamoto K, Matsuno S, Kudo T.

Cancer Immunol Immunother. 2003 Feb;52(2):97-106. Epub 2003 Jan 18.

PMID:
12594573
7.

A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL.

Ju SW, Ju SG, Wang FM, Gu ZJ, Qiu YH, Yu GH, Ma HB, Zhang XG.

Hybrid Hybridomics. 2003 Oct;22(5):333-8.

PMID:
14678652
8.

Role of 4-1BB:4-1BB ligand in cancer immunotherapy.

Cheuk AT, Mufti GJ, Guinn BA.

Cancer Gene Ther. 2004 Mar;11(3):215-26. Review.

PMID:
14671675
9.

Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.

Salih HR, Schmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, Nuessler V, Kiener PA.

J Immunol. 2001 Oct 1;167(7):4059-66.

10.

Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis.

Saito K, Ohara N, Hotokezaka H, Fukumoto S, Yuasa K, Naito M, Fujiwara T, Nakayama K.

J Biol Chem. 2004 Apr 2;279(14):13555-63. Epub 2004 Jan 16.

11.

Molecular and biological characterization of human 4-1BB and its ligand.

Alderson MR, Smith CA, Tough TW, Davis-Smith T, Armitage RJ, Falk B, Roux E, Baker E, Sutherland GR, Din WS.

Eur J Immunol. 1994 Sep;24(9):2219-27.

PMID:
8088337
12.

4-1BB: still in the midst of darkness.

Kwon B, Moon CH, Kang S, Seo SK, Kwon BS.

Mol Cells. 2000 Apr 30;10(2):119-26. Review.

13.

Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.

Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA, Kiener PA.

J Immunol. 2000 Sep 1;165(5):2903-10.

15.

Role of 4-1BB in immune responses.

Vinay DS, Kwon BS.

Semin Immunol. 1998 Dec;10(6):481-9. Review.

PMID:
9826581
16.

Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family.

Gravestein LA, Blom B, Nolten LA, de Vries E, van der Horst G, Ossendorp F, Borst J, Loenen WA.

Eur J Immunol. 1993 Apr;23(4):943-50.

PMID:
8384562
17.

Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.

Liu GZ, Gomes AC, Putheti P, Karrenbauer V, Kostulas K, Press R, Hillert J, Hjelmström P, Gao XG.

Scand J Immunol. 2006 Oct;64(4):412-9.

PMID:
16970683
18.

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.

Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H, Okumura K, Watts TH.

J Immunol. 2001 Aug 1;167(3):1313-24.

19.

Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes.

Nam KO, Kang H, Shin SM, Cho KH, Kwon B, Kwon BS, Kim SJ, Lee HW.

J Immunol. 2005 Feb 15;174(4):1898-905.

20.

Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.

Cho HR, Kwon B, Yagita H, La S, Lee EA, Kim JE, Akiba H, Kim J, Suh JH, Vinay DS, Ju SA, Kim BS, Mittler RS, Okumura K, Kwon BS.

Transpl Int. 2004 Aug;17(7):351-61. Epub 2004 Jul 31.

PMID:
15349720
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk